Dermatitis atopic aggravated and Hearing loss

Summary:

Hearing loss is found among people with Dermatitis atopic aggravated, especially for people who are female, 60+ old.

The study analyzes which people have Hearing loss with Dermatitis atopic aggravated. It is created by eHealthMe based on reports of 32 people who have Dermatitis atopic aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dermatitis atopic aggravated?

Dermatitis atopic aggravated (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 617 drugs and 179 conditions by eHealthMe. Check the latest studies of Dermatitis atopic aggravated.

What is Hearing loss?

Hearing loss is found to be associated with 1,351 drugs and 2,377 conditions by eHealthMe. Check the latest studies of Hearing loss.



On May, 08, 2026

32 people who have Dermatitis Atopic Aggravated and Hearing Loss are studied.

Would you have Hearing loss when you have Dermatitis atopic aggravated?

Gender of people who have Dermatitis Atopic Aggravated and experienced Hearing Loss *:

  • female: 56.67 %
  • male: 43.33 %

Age of people who have Dermatitis Atopic Aggravated and experienced Hearing Loss *:

  • 0-1: 0.0 %
  • 2-9: 20 %
  • 10-19: 0.0 %
  • 20-29: 12 %
  • 30-39: 0.0 %
  • 40-49: 4 %
  • 50-59: 16 %
  • 60+: 48 %

Common co-existing conditions for these people *:

  1. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 1 person, 3.12%
  2. Rash Erythematous (redness of the skin): 1 person, 3.12%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 3.12%
  4. Osteoporosis (bones weak and more likely to break): 1 person, 3.12%
  5. Neck Pain: 1 person, 3.12%
  6. Migraine (headache): 1 person, 3.12%
  7. Menopause (end of monthly cycles in women): 1 person, 3.12%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.12%
  9. High Blood Pressure: 1 person, 3.12%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.12%

Common drugs taken by these people *:

  1. Dupixent: 18 people, 56.25%
  2. Rinvoq: 6 people, 18.75%
  3. Prednisone: 3 people, 9.38%
  4. Levetiracetam: 3 people, 9.38%
  5. Vitamin D3: 1 person, 3.12%
  6. Lisinopril: 1 person, 3.12%
  7. Ammonium Lactate: 1 person, 3.12%
  8. Azithromycin: 1 person, 3.12%
  9. Cibinqo: 1 person, 3.12%
  10. Codeine: 1 person, 3.12%

Common symptoms for these people *:

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 4 people, 12.50%
  2. Vision Blurred: 4 people, 12.50%
  3. Headache (pain in head): 4 people, 12.50%
  4. Tinnitus (a ringing in the ears): 4 people, 12.50%
  5. Itching: 4 people, 12.50%
  6. Weakness: 3 people, 9.38%
  7. Dehydration (dryness resulting from the removal of water): 3 people, 9.38%
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 9.38%
  9. Fatigue (feeling of tiredness): 3 people, 9.38%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hearing loss?

- Check whether Hearing loss is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hearing loss:

All the conditions that are associated with Hearing loss:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hearing loss and Dermatitis atopic aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: